Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Bioventus (BVS) Return on Capital Employed (2021 - 2026)

Bioventus filings provide 5 years of Return on Capital Employed readings, the most recent being 10.14% for Q4 2025.

  • On a quarterly basis, Return on Capital Employed rose 1296.0% to 10.14% in Q4 2025 year-over-year; TTM through Dec 2025 was 10.14%, a 1296.0% increase, with the full-year FY2025 number at 9.9%, up 1261.0% from a year prior.
  • Return on Capital Employed hit 10.14% in Q4 2025 for Bioventus, up from 7.78% in the prior quarter.
  • In the past five years, Return on Capital Employed ranged from a high of 10.14% in Q4 2025 to a low of 33.35% in Q3 2023.
  • Median Return on Capital Employed over the past 5 years was 2.87% (2022), compared with a mean of 4.53%.
  • Biggest five-year swings in Return on Capital Employed: crashed -3046bps in 2023 and later surged 2926bps in 2024.
  • Bioventus' Return on Capital Employed stood at 1.59% in 2021, then plummeted by -1074bps to 15.47% in 2022, then grew by 17bps to 12.86% in 2023, then soared by 78bps to 2.82% in 2024, then surged by 459bps to 10.14% in 2025.
  • The last three reported values for Return on Capital Employed were 10.14% (Q4 2025), 7.78% (Q3 2025), and 6.74% (Q2 2025) per Business Quant data.